|
業務類別
|
-- |
|
業務概覽
|
Brii Biosciences Ltd is a biotechnology company based in China and the United States. It is committed to developing advancing therapies for infectious diseases, such as HBV, HIV, MDR/XDR gram-negative infections, and other illnesses, such as CNS diseases, which have public health burdens in China and around the world. The company's pipeline of products includes more than 10 product candidates that focus on infectious diseases and mental illnesses. |
| 公司地址
| No. 1 North Yongtaizhuang Road, 3rd Floor, Building 7, Zhongguancun Dongsheng, International Science Park, Beijing, CHN, 100192 |
| 電話號碼
| -- |
| 傳真號碼
| -- |
| 公司網頁
| https://www.briibio.com |
| 員工數量
| 98 |
| Dr. Ankang Li |
Director, Chief Financial Officer, Secretary and Chief Strategy Officer |
-- |
25/04/2024 |
| Dr. Zhi Hong,PhD |
Executive Chairman of the Board and Chief Executive Officer |
-- |
25/04/2024 |
|
|
| Dr. Ankang Li |
Director, Chief Financial Officer, Secretary and Chief Strategy Officer |
25/04/2024 |
| Dr. Taiyin Yang, PhD |
Independent Director |
25/04/2024 |
| Mr. Gregg H. Alton, J.D. |
Independent Director |
25/04/2024 |
| Mr. Robert Taylor Nelsen |
Director |
25/04/2024 |
| Dr. Zhi Hong,PhD |
Executive Chairman of the Board and Chief Executive Officer |
25/04/2024 |
| Dr. Martin Murphy, Jr |
Independent Director |
25/04/2024 |
| Mr. Yiu Wa Alec Tsui |
Independent Director |
25/04/2024 |
| Ms. Hui Grace Tang |
Independent Director |
25/04/2024 |
|
|
|
|
